期刊文献+

重症肺炎患者copeptin与病情严重性、预后及应激性高血糖的关系 被引量:20

Correlation between copeptin and the disease severity, outcome and stress hyperglycemia in severe pneumonia patients
原文传递
导出
摘要 目的探讨copeptin与重症肺炎患者应激性高血糖、病情严重程度以及预后的关系。方法采用前瞻性观察研究,入选45例重症肺炎患者。入院时采集静脉血标本检测copeptin。记录入ICU时血气分析、CRP、血糖、APACHEⅡ值等基本资料;对血糖≥10.0mmol/L给予胰岛素治疗,记录24h短效胰岛素总量;随访患者28d后的生存情况。结果患者入院时copeptin和APACHEⅡ正相关(r=0.481,P=0.001);死亡组较存活组copeptin水平(pmol/L)明显升高(75.18±30.42郴.52.78±22.82,P=0.007);入院时copeptin和血糖呈正相关(r=0.417,P=0.004);需要胰岛素治疗者,入院时copeptin和24h胰岛素总量正相关(r=0.556,P=0.009);多因素COX回归分析示copeptin是28d死亡独立危险因素(P=0.005,OR=1.022,95%CI:1.00—1.044);ROC曲线下面积为0.7409(P=0.006)。结论重症肺炎患者copeptin和APACHEⅡ、应激性高血糖呈正相关,反映病情严重程度、应激性高血糖控制的难易程度,可以预测患者预后。 Objective To study the changes of plasma copeptin level in pneumonia patients and to explore the correlation between copeptin and disease severity, outcome as well as stress hyperglycemia. Methods A total of 45 patients with severe pneumonia were included in a prosPective observation. The plasma levels of copeptin, CRP and blood glucose were measured after admission, and the APACHE Ⅱ scores were recorded within 24 hours. The patients were given insulin therapy by intravenous micro-dosage pump, and the total doses of insulin were recorded. All the patients with 28-day survival were followed up. Results The plasma levels of copeptin of severe pneumonia patients after admission were positively correlated with APACHE Ⅱ ( r = 0. 481, P = 0. 001 ) and blood glucose ( r = 0. 417, P = 0. 004), and were also correlated with the total insulin doses in patients under insulin therapy ( blood glucose≥ 10. 0 mmol/L). The plasma levels of copeptin of the survival group were significanatly higher than the non- survival group, COX regression multivariate analysis showed that copeptin was an independent risk factor of death in severe pneumonia patients ( P = 0. 005, OR = 1. 022, 95% CI: 1.00 - 1. 044), and the area under the ROC curve was 0. 740 9 ( P = 0. 006 ). Conclusion The plasma levels in all patients with copeptin of severe pneumonia after admission is positively correlated with APACHEⅡ and stresshyperglycemia, suggesting a useful approach to the judgment of disease severity, outcome and glucose control.
出处 《中华急诊医学杂志》 CAS CSCD 北大核心 2016年第3期338-342,共5页 Chinese Journal of Emergency Medicine
关键词 COPEPTIN 重症肺炎 APACHEⅡ 预后 应激性高血糖 Copeptin Severe pneumonia APACHEⅡ Prognosi Stress hyperglycemia
  • 相关文献

参考文献24

  • 1Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults [J]. Clin Infect Dis, 2007, 44 (Suppl 2): $27-72. DOI: 10. 1086/511159.
  • 2Magee MC. Improving IV insulin administration in a community hospital [J] . J Vis Exp, 2012 (64): e3705. DOI: 10.3791/ 3705.
  • 3NICE-SUGAR Study Investigators al. The NICE-SUGAR Study Finfer S, Chittock DR, Su SY, et Investigators. Intensive versus conventional glu-cose control in critically illpatients [ J ] . N Engl JMed, 2009, 360 (13) : 1283-1297. DOI: 10. 1056/NEJMoa0810625.
  • 4Balanescu S, Kopp P, Gaskill MB, et al. Correlation of plasma copeptin and vasopressin concentrations in hypo-, iso-, and hyperosmolar States [ J ] . J Clin Endocrinol Metab, 2011, 96 (4) : 1046-1052. DOI: 10. 1210/jc. 2010-2499.
  • 5Griebel G, Stemmelin J, Gal CS, et al. Non-peptide vasoprcssin Vlb receptor antagonists as potential drugs for the treatment of stress-related disorders [J] . Curr Pharm Des, 2005, 11 (12) : 1549-1559.
  • 6Karbek B, Ozbek M, Karakose M, et al. Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome [ J ] . J Ovarian Res, 2014, 7: 31. DOh 10. 1186/1757-2215-7-31.
  • 7Morgenthaler NG, Struck J, Jochberger S, et al. Copeptin : clinical use of a new biomarker [J] . Trends Endocrinol Metab, 2008, 19 (2) : 43-49. DOI: 10. 1016/j, tem. 2007. 11. 001.
  • 8Morgenthaler NG, Mtiller B, Struck J, et al. Copeptin, a stable peptide of the arginine/ vasopressin precursor, is elevated in hemorrhagic and septic shock [J] . Shock, 2007, 28 (2) : 219- 226. DOI: 10. 1097/SHK. ObO13e318033eSda.
  • 9Morgenthaler NG, Struck J, Alonso C, et al. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin [ J]. Clin Chem, 2006, 52 ( 1 ) : 112- 119. DOI: 10. 1373/clinchem. 2005. 060038.
  • 10Dobsa L, Edozien KC. Copeptin and its potential role in diagnosis and prognosis of various diseases [ J ]. Biochem Med( Zagreb), 2013, 23 (2) : 172-190.

二级参考文献33

  • 1社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3040
  • 2Mandell LA,Wunderink RG,Anzueto A, etal. Infections Diseases Society of America/American Thoracic Society consensus guide- lines on the management of community-acquired pneumonia in a- dults[J]. Clin Infect Dis,2007,44(Suppl 2) :S27-S72.
  • 3Barten G, Schtitte H, Bals R, et al. Symposium: Pneumonia 2010-state of the art[J]. Pneumologie, 2011,65(4) : 223-228.
  • 4Niederman MS. Making sense of scoring systems in communi- ty-acquired pneumonia [J]. Respirology, 2009, 14 (3): 327- 335.
  • 5Volpi S, Rabadan - Diehl C, Aguilera G. Vasopressinergic regu-lation of the hypothalamic pituitary adrenal axis and stress adapta-tion[J]. Stress, 2004,7(2) : 75 -83.
  • 6Morgenthaler NG, Struck J, Alonso C, et al. Assay for the meas-urement of copeptin,a stable peptide derived from the precursor ofvasopressin[J]. Clin Chem, 2006, 52(1) : 112-119.
  • 7Nickel CH,Bingisser R,Morgenthaler NG. The role of copeptinas a diagnostic and prognostic biomarker for risk stratification inthe emergency department[ J]. BMC Med, 2012, 10( 1 ) : 7.
  • 8Lippi G, Plebani M, Di Somma S, et al. Considerations for earlyacute myocardial infarction rule - out for emergency departmentchest pain patients : the case of copeptin [ J ]. Clin Chem LabMed, 2012, 50(2) : 243 -253.
  • 9Reichlin T,Hochholzer W, Stelzig C, et al. Incremental value ofcopeptin for rapid rule out of acute myocardial infarction[ J]. J AmColl Cardiol, 2009,54( 1) : 60 - 68.
  • 10Potocki M, Reichlin T, Thalmann S, et al. Diagnostic and prog-nostic impact of copeptin and high - sensitivity cardiac troponin Tin patients with pre - existing coronary artery disease and suspec-ted acute myocardial infarction[ J]. Heart, 2012,98(7) : 558 -565.

共引文献34

同被引文献207

引证文献20

二级引证文献205

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部